The risk of blood clots after COVID-19 vaccinations is very low finds a new study of 46-million adults in England. The research, which involved University of Bristol academics, showed that people vaccinated with Oxford-AstraZeneca or Pfizer-BioNTech had a lower risk of all venous clots (such as deep vein thrombosis and pulmonary embolism) and all arterial clots (such as strokes and heart attacks), particularly in people over 70 years.
What people with heart disease should know about vaccines today
U.S. Agencies Push for Pause of J&J COVID-19 Vaccine After Patients Develop Rare Blood Clots
Blood clot risk remains elevated nearly a year after COVID-19
Peripheral Matters COVID-19 and the Risk of Thrombosis: Insights from the CORONA-VTE Registry - American College of Cardiology
Long COVID research after the public health emergency ends : Short Wave : NPR
COVID-19: Risk of blood clot increases for up to six months after having virus study finds, UK News
Coronavirus blood-clot mystery intensifies
Genetic risk factor for clotting after COVID-19 infection - Medicine, Nursing and Health Sciences
What do you do if you think you have VITT? What we know of the rare clotting disorder
Clot risk far lower from vaccines than virus: UK study, Coronavirus pandemic News